In this new episode of La Loupe, we assess whether they are really risk-free with Stéphanie Benz and Victor Garcia, journalists in the Sciences and Health department of L’Express.
FIND ALL THE EPISODES OF THE MAGNIFIER
Listen to this episode and subscribe to La Loupe on Apple Podcasts, Spotify, Deezer, Google Podcasts, Addict Podcast And Amazon Music.
The team: Mathias Penguilly (writing), Charlotte Baris (presentation) and Jules Krot (editing and production).
Music and dressing: Emmanuel Herschon/Studio Torrent
Credits: ABC, ABC News, CBS Inside Edition, NBC Today, TikTok
Image credits: Joël Saget/AFP
Logo: Anne-Laure Chapelain/Benjamin Chazal
How to listen to a podcast? follow the leader.
Charlotte Baris: Our topic of the day begins in the United States, on social networks, with some TV stars and slimming influencers. It’s the start of 2022 and America thinks it has found the miracle cure for excess pounds. On both sides of the continent, thousands are documenting their weight loss, and filming themselves injecting the drug. The phenomenon could have stopped there, but it really exploded when high-profile celebrities also admitted to using these products. First there was Elon Musk, the technology mogul, in an interview in October 2022 and more recently, Oprah Winfrey, American television superstar…
We are then on the eve of Christmas 2023 and the American media are inflamed: the host is not promoting any specific drug, but the excitement is impressive. If I tell you about these new so-called miraculous drugs, it’s because they are starting to sweep across the world – including France. At a time when the rate of obesity in the world is exploding, have we found the ideal remedy? Or on the contrary, are we preparing for a new health scandal? We explain everything to you in this episode of La Loupe…
For further :
Obesity: the study which shows a worrying progression in the world
Obesity: the urgency of a new roadmap
Tomorrow all thin? Investigation into the anti-obesity drug revolution
Anti-obesity drugs: a major challenge for public authorities
Anti-obesity drugs: the 100 billion euro battle between Novo and Lilly laboratories
Agri-food, textiles, airplanes… Will anti-obesity drugs disrupt the economy?
Obesity: is there really a French exception?